CTOs on the Move

Innovatient Solutions

www.innovatient.com

 
Innovatient helps healthcare organizations deliver better care through an interactive patient experience and engagement technology platform. The highly customizable software provides an easy-to-use solution delivered via TV, tablet, or bedside monitor engaging patients during treatment and after they go home, fostering an environment of wellness and improved outcomes. Our integrated nurse rounding, communication, and patient education tools result in improved patient satisfaction scores (HCAHPS) transforming the patient experience creating long-term relationships with healthcare providers.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Vitamin Angels

Vitamin Angels is a non-profit organization that distributes lifesaving and life-changing vitamins and minerals to children and mothers in need, working to improve maternal and child nutrition worldwide.

Theratechnologies

Theratechnologies is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs.

Impact Instrumentation

Impact Instrumentation is a West Caldwell, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Avera Queen of Peace Health Services

Avera Queen of Peace Health Services is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Mitchell, SD. To find more information about Avera Queen of Peace Health Services, please visit www.averaqueenofpeace.org

StemCells

StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimer’s disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.